Clinical Trials Arena on MSN

Kamada enrols first subject in Cytogam trial for CMV infection

The controlled multi-centre, randomised, prospective trial is investigating the therapy in kidney transplant recipients.
Pharmabiz

Kamada begins patient enrolment in an investigator-initiated clinical trial of Cytogam to prevent cytomegalovirus in kidney transplantation

Kamada begins patient enrolment in an investigator-initiated clinical trial of Cytogam to prevent cytomegalovirus in kidney transplantation: Rehovot, Israel Thursday, November 6, ...
Business Insider

Kamada Announces First Patient Enrolled into an Investigator-Initiated Clinical Trial of CYTOGAM® to Prevent Cytomegalovirus in Kidney Transplantation

REHOVOT, Israel, and HOBOKEN, N.J. , Nov. 04, 2025 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company with a portfolio of marketed products indicated for ...
eLife

Apparent cooperativity between human CMV virions introduces errors in conventional methods of calculating multiplicity of infection

Whether infection of cells by individual virions occurs randomly or if there is some form (s) of competition or cooperativity between individual virions remains largely unknown for most virus-cell ...
Hosted on MSN

Moderna drops as late-stage cytomegalovirus vaccine trial fails

Moderna (NASDAQ:MRNA) announced that its late-stage trial for the mRNA-1647 vaccine, aimed at preventing cytomegalovirus infection, did not achieve its primary objective. The stock is down 3.9% after ...